Akari Therapeutics PLC (AKTX)
1.36
-0.11
(-7.48%)
USD |
NASDAQ |
May 03, 16:00
1.39
+0.03
(+2.21%)
After-Hours: 20:00
Akari Therapeutics Price: 1.36 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 1.579 | 1.59 | 1.33 | 1.36 | 20479.00 |
| May 02, 2024 | 1.69 | 1.868 | 1.428 | 1.47 | 38277.00 |
| May 01, 2024 | 1.54 | 1.854 | 1.514 | 1.70 | 165143.0 |
| Apr 30, 2024 | 1.300 | 1.54 | 1.29 | 1.54 | 43763.00 |
| Apr 29, 2024 | 1.18 | 1.351 | 1.18 | 1.280 | 22039.00 |
| Apr 26, 2024 | 1.185 | 1.20 | 1.17 | 1.185 | 10002.00 |
| Apr 25, 2024 | 1.20 | 1.20 | 1.17 | 1.19 | 3902.00 |
| Apr 24, 2024 | 1.21 | 1.21 | 1.170 | 1.19 | 7532.00 |
| Apr 23, 2024 | 1.13 | 1.235 | 1.13 | 1.21 | 4872.00 |
| Apr 22, 2024 | 1.13 | 1.22 | 1.13 | 1.18 | 13919.00 |
| Apr 19, 2024 | 1.11 | 1.20 | 1.080 | 1.166 | 3740.00 |
| Apr 18, 2024 | 1.14 | 1.225 | 1.11 | 1.21 | 8776.00 |
| Apr 17, 2024 | 1.10 | 1.238 | 1.078 | 1.121 | 7933.00 |
| Apr 16, 2024 | 1.20 | 1.25 | 1.136 | 1.156 | 14524.00 |
| Apr 15, 2024 | 1.23 | 1.270 | 1.20 | 1.20 | 9109.00 |
| Apr 12, 2024 | 1.21 | 1.27 | 1.21 | 1.21 | 28156.00 |
| Apr 11, 2024 | 1.300 | 1.40 | 1.10 | 1.10 | 37351.00 |
| Apr 10, 2024 | 1.200 | 1.33 | 1.19 | 1.30 | 11273.00 |
| Apr 09, 2024 | 1.41 | 1.49 | 1.265 | 1.315 | 7481.00 |
| Apr 08, 2024 | 1.42 | 1.50 | 1.20 | 1.40 | 5390.00 |
| Apr 05, 2024 | 1.45 | 1.53 | 1.41 | 1.41 | 3798.00 |
| Apr 04, 2024 | 1.53 | 1.58 | 1.430 | 1.44 | 27922.00 |
| Apr 03, 2024 | 1.51 | 1.580 | 1.51 | 1.55 | 14093.00 |
| Apr 02, 2024 | 1.53 | 1.555 | 1.51 | 1.51 | 8244.00 |
| Apr 01, 2024 | 1.85 | 1.85 | 1.50 | 1.51 | 111812.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.10
Minimum
Apr 11 2024
77.60
Maximum
Feb 19 2021
25.71
Average
31.00
Median
Apr 13 2020
Price Benchmarks
| DBV Technologies SA | 0.6669 |
| Cellectis SA | 2.99 |
| Adaptimmune Therapeutics PLC | 1.19 |
| Biodexa Pharmaceuticals Plc | 1.18 |
| NuCana PLC | 4.00 |
Price Related Metrics
| Earnings Yield | -150.3% |
| Market Cap | 10.78M |